Health and Healthcare
5867 Articles
Savara shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary…
Whether you were in favor of or against the Affordable Care Act, it is likely of little surprise that the…
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…
The May 31 short interest data have been compared with the previous figures, and short interest in most of these…
One relatively small clinical-stage biopharmaceutical player called Global Blood Therapeutics may be about to change how sickle cell disease treatment…
Zynerba Pharma has just announced that the U.S. Patent and Trademark Office has issued a patent for the firm’s treatment…
CymaBay Therapeutics shares were nearly halved early Tuesday after the company provided an update from its midstage study of seladelpar…
NovaBay shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on…
A monoclonal antibody called teplizumab has been shown to delay the onset of type 1 diabetes for as long as…
ReWalkshares took a step back on Monday after the firm announced that it would be pricing a registered direct offering…
Fentanyl-maker Insys Therapeutics has filed for bankruptcy protection while the company sells all its assets.
24/7 Wall St. has taken a look at Wedbush’s recent ASCO roundup, and we’ve picked out a few of the…
The problem of fake news has spread to health news, which can be critical to the well being of millions…
Proton pump inhibitors (PPIs) — a widely prescribed group of medications that combat heartburn, GERD (gastroesophageal reflux disease), and ulcers…
InflaRx shares were destroyed on Wednesday after the firm announced results from its midstage trial in patients suffering from moderate…
Our top personal finance-related articles today. Your wallet will thank you later.